Amplification and co-regulators of androgen receptor gene in prostate cancer
Prostate cancer isthe second most common malignancy among males after lung cancer. The growth of prostate cancer cells depends on the presence of androgens, a group ofsteroid hormones that include testosterone and its more active metabolite dihydrotestosterone. Most prostate cancers are androgen-d...
Збережено в:
| Дата: | 2009 |
|---|---|
| Автори: | , , , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
| Назва видання: | Experimental Oncology |
| Теми: | |
| Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/134927 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Amplification and co-regulators of androgen receptor gene in prostate cancer / Ch. Golias, I. Iliadis, D. Peschos, K. Charalabopoulos // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 3-8. — Бібліогр.: 46 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| Резюме: | Prostate cancer isthe second most common malignancy among males after lung cancer. The growth of prostate cancer cells depends
on the presence of androgens, a group ofsteroid hormones that include testosterone and its more active metabolite dihydrotestosterone.
Most prostate cancers are androgen-dependent and respond to the antiandrogens or androgen-deprivation therapy. However,
the progression to an androgen-independent stage occurs frequently. Possible mechanisms that could be involved in the development
of hormone resistant prostate cancer causes including androgen receptor (AR) mutations, AR amplification/over expression,
interaction between AR and other growth factors, and enhanced signaling in a ligand-independent manner are discussed. |
|---|